• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Michael Hassett, MD, MPH


  • Hassett MJ, McNiff KK, Dicker AP, Gilligan T, Hendricks CB, Lennes I, Murray T, Krzyzanowska MK.High-Priority Topics for Cancer Quality Measure Development: Results of the 2012 American Society of Clinical Oncology Collaborative Cancer Measure Summit.J Oncol Pract. 2014 Feb 18.
  • Weingart SN, Zhu J, Young-Hong J, Vermilya HB, Hassett M.Do drug interaction alerts between a chemotherapy order-entry system and an electronic medical record affect clinician behavior?.J Oncol Pharm Pract. 2013 Jun 26.
  • Soeteman DI, Stout NK, Ozanne EM, Greenberg C, Hassett MJ, Schrag D, Punglia RS.Modeling the effectiveness of initial management strategies for ductal carcinoma in situ.Journal of the National Cancer Institute. 2013 Jun 5;105(11):774-81.
  • Brooks GA, Li L, Sharma DB, Weeks JC, Hassett MJ, Yabroff KR, Schrag D.Regional variation in spending and survival for older adults with advanced cancer.Journal of the National Cancer Institute. 2013 May 1;105(9):634-42.
  • Weingart SN, Mattsson T, Zhu J, Shulman LN, Hassett M.Improving electronic oral chemotherapy prescription: can we build a safer system?.J Oncol Pract. 2012 Nov;8(6):e168-73.
  • Abel GA, Chen K, Taback N, Hassett MJ, Schrag D, Weeks JC.Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptions.Cancer. 2013 Mar 1;119(5):1065-72.
  • Hassett MJ, Ritzwoller DP, Taback N, Carroll N, Cronin AM, Ting GV, Schrag D, Warren JL, Hornbrook MC, Weeks JC.Validating Billing/Encounter Codes as Indicators of Lung, Colorectal, Breast, and Prostate Cancer Recurrence Using 2 Large Contemporary Cohorts.Med Care. 2012 Dec 6.
  • Yung RL, Hassett MJ, Chen K, Gesten FC, Roohan PJ, Boscoe FP, Sinclair AH, Schymura MJ, Schrag D.Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer.Journal of the National Cancer Institute. 2012 Jul 18;104(14):1102-5.
  • Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, Hudis CA, Marcom PK, Pettinga JE, Share D, Theriault R, Wong YN, Vandergrift JL, Niland JC, Weeks JC.Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.J Clin Oncol. 2012 Jun 20;30(18):2218-26.
  • Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong YN, Lee SJ, Hassett MJ.Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.Cancer. 2012 Jun 6.
  • Hassett MJ, Rao SR, Brozovic S, Stahl JE, Schwartz JH, Maloney B, Jacobson JO.Chemotherapy-related hospitalization among community cancer center patients.Oncologist. 2011;16(3):378-87.
  • Hu YY, Weeks CM, In H, Dodgion CM, Golshan M, Chun YS, Hassett MJ, Corso KA, Gu X, Lipsitz SR, Greenberg CC.Impact of neoadjuvant chemotherapy on breast reconstruction.Cancer. 2011 Jan 24.
  • Punglia RS, Hassett MJ.Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors.J Clin Oncol. 2010 Sep 20;28(27):4108-10.
  • Hassett MJ.The full burden of cancer.Oncologist. 2010;15(8):793-5.
  • Phillips KA, Marshall DA, Haas JS, Elkin EB, Liang SY, Hassett MJ, Ferrusi I, Brock JE, Van Bebber SL.Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients.Cancer. 2009 Nov 15;115(22):5166-74.
  • Hassett MJ,O'Malley AJ,Keating NL.Factors influencing changes in employment among women with newly diagnosed breast cancer.Cancer. 2009 Jun 15;115(12):2775-82.
  • Hassett MJ,Griggs JJ.Disparities in breast cancer adjuvant chemotherapy: moving beyond yes or no.J Clin Oncol. 2009 May 1;27(13):2120-1.
  • Friese CR,Neville BA,Edge SB,Hassett MJ,Earle CC.Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data.Cancer. 2009 Feb 15;115(4):716-24.
  • Azzone V,Frank RG,Pakes JR,Earle CC,Hassett MJ.Behavioral health services for women who have breast cancer.J Clin Oncol. 2009 Feb 10;27(5):706-12.
  • Hassett MJ,Hughes ME,Niland JC,Edge SB,Theriault RL,Wong YN,Wilson J,Carter WB,Blayney DW,Weeks JC.Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.J Clin Oncol. 2008 Dec 1;26(34):5553-60.
  • Hassett MJ,Hughes ME,Niland JC,Ottesen R,Edge SB,Bookman MA,Carlson RW,Theriault RL,Weeks JC.Selecting high priority quality measures for breast cancer quality improvement.Med Care. 2008 Aug;46(8):762-70.
  • Hassett MJ, O'Malley AJ, Pakes JR, Newhouse JP, Earle CC.Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.Journal of the National Cancer Institute. 2006 Aug 16;98(16):1108-17.